MDWD Mediwound Ltd.

MediWound Ltd is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and others.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  03/20/2014
Outstanding shares:  27,236,752
Average volume:  114,242
Market cap:   $68,091,880
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M68830104
ISIN:        IL0011316309
Valuation   (See tab for details)
PE ratio:   -5.88
PB ratio:   30.77
PS ratio:   2.73
Return on equity:   1,354.81%
Net income %:   -44.58%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy